Stock Taper
EXCHANGE TRADED FUND

FTXH

First Trust Nasdaq Pharmaceuticals ETF
$41.33 ▼ 1.60%
−$0.67 TODAY

FUND FACTS

Manager First Trust
Assets $1.05B
Expense ratio 0.60%
Inception Sep 20, 2016
Asset class Sector Equity
Holdings 49
Volume 81.61K
Avg volume 561.73K

ABOUT THIS FUND

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%.

PRICE

$41.33 ▼ DOWN 1.60% (−$0.67)
$41.20$41.40$41.609:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM41.33

HOLDINGS

TOP 20 OF 49 · 76.82% OF THE FUND
RANK STOCK WEIGHT SHARES VALUE
01 MRK Merck & Co., Inc. 7.59% 540.13K $80.13M
02 LLY Eli Lilly and Company 7.05% 63.38K $74.44M
03 ABBV AbbVie Inc. 6.98% 288.2K $73.63M
04 JNJ Johnson & Johnson 6.84% 269.29K $72.18M
05 BMY Bristol-Myers Squibb Company 6.77% 1.07M $71.41M
06 BIIB Biogen Inc. 3.61% 174.26K $38.08M
07 AMGN Amgen Inc. 3.54% 86.35K $37.34M
08 VTRS Viatris Inc. 3.47% 2.24M $36.61M
10 CAH Cardinal Health, Inc. 3.25% 146.13K $34.28M
12 PFE Pfizer Inc. 3.20% 1.21M $33.82M
13 GILD Gilead Sciences, Inc. 3.10% 224.34K $32.68M
14 INCY Incyte Corporation 2.44% 206.97K $25.74M
16 JAZZ Jazz Pharmaceuticals plc 2.34% 101.19K $24.74M
17 ILMN Illumina, Inc. 2.27% 110.88K $23.9M
18 ZTS Zoetis Inc. 1.87% 255K $19.72M
20 EXEL Exelixis, Inc. 1.61% 311.2K $16.94M

SECTOR HOLDINGS

TECHNOLOGY IS 100.00% OF THE FUND
Healthcare 100.00%

BY REGION

UNITED STATES IS 95.80% OF THE FUND
United States 95.80%
Ireland 3.53%
United Kingdom 0.54%
Other 0.14%